Splenomegaly: Difference between revisions
Line 184: | Line 184: | ||
* [[Esophageal varices]] | * [[Esophageal varices]] | ||
|- | |- | ||
! rowspan=" | ! rowspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignancy | ||
! colspan="2" align="center" style="background:#DCDCDC;" |[[Lymphoma]]<ref name="pmid25131182">{{cite journal |vauthors=Ishibashi N, Maebayashi T, Aizawa T, Sakaguchi M, Abe O, Saito T, Tanaka Y |title=Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma |journal=Hematology |volume=20 |issue=4 |pages=203–7 |date=May 2015 |pmid=25131182 |doi=10.1179/1607845414Y.0000000192 |url=}}</ref> | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Lymphoma]]<ref name="pmid25131182">{{cite journal |vauthors=Ishibashi N, Maebayashi T, Aizawa T, Sakaguchi M, Abe O, Saito T, Tanaka Y |title=Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma |journal=Hematology |volume=20 |issue=4 |pages=203–7 |date=May 2015 |pmid=25131182 |doi=10.1179/1607845414Y.0000000192 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 556: | Line 556: | ||
* [[Disseminated intravascular coagulation|DIC]] | * [[Disseminated intravascular coagulation|DIC]] | ||
|- | |- | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ||
Line 586: | Line 585: | ||
! rowspan="13" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection | ! rowspan="13" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection | ||
! rowspan="3" align="center" style="background:#DCDCDC;" |[[Virus|Viral]] | ! rowspan="3" align="center" style="background:#DCDCDC;" |[[Virus|Viral]] | ||
! align="center" style="background:#DCDCDC;" |[[Hepatitis]] | ! align="center" style="background:#DCDCDC;" |[[Hepatitis]]<ref name="pmid23904062">{{cite journal |vauthors=Kumar KJ, Kumar HC, Manjunath VG, Anitha C, Mamatha S |title=Hepatitis A in children- clinical course, complications and laboratory profile |journal=Indian J Pediatr |volume=81 |issue=1 |pages=15–9 |date=January 2014 |pmid=23904062 |doi=10.1007/s12098-013-1114-8 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Infection | * Infection | ||
Line 627: | Line 626: | ||
* [[Encephalomyelitis]] | * [[Encephalomyelitis]] | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Mononucleosis|Infectious mononucleosis]] | ! align="center" style="background:#DCDCDC;" |[[Mononucleosis|Infectious mononucleosis]]<ref name="pmid21191775">{{cite journal |vauthors=Gao LW, Xie ZD, Liu YY, Wang Y, Shen KL |title=Epidemiologic and clinical characteristics of infectious mononucleosis associated with Epstein-Barr virus infection in children in Beijing, China |journal=World J Pediatr |volume=7 |issue=1 |pages=45–9 |date=February 2011 |pmid=21191775 |doi=10.1007/s12519-011-0244-1 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* EBV | * EBV | ||
Line 655: | Line 654: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Cytomegalovirus]] | ! align="center" style="background:#DCDCDC;" |[[Cytomegalovirus]]<ref name="pmid25308607">{{cite journal |vauthors=Smiechura M, Strużycka M, Konopka W |title=Congenital and acquired cytomegalovirus infection and hearing evaluation in children |journal=Otolaryngol Pol |volume=68 |issue=6 |pages=303–7 |date=2014 |pmid=25308607 |doi=10.1016/j.otpol.2014.04.003 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 683: | Line 682: | ||
|- | |- | ||
! rowspan="3" align="center" style="background:#DCDCDC;" |[[Bacteria|Bacterial]] | ! rowspan="3" align="center" style="background:#DCDCDC;" |[[Bacteria|Bacterial]] | ||
! align="center" style="background:#DCDCDC;" |[[Salmonella]] | ! align="center" style="background:#DCDCDC;" |[[Salmonella]]<ref name="pmid26068006">{{cite journal |vauthors=Rosche KL, Aljasham AT, Kipfer JN, Piatkowski BT, Konjufca V |title=Infection with Salmonella enterica Serovar Typhimurium Leads to Increased Proportions of F4/80+ Red Pulp Macrophages and Decreased Proportions of B and T Lymphocytes in the Spleen |journal=PLoS ONE |volume=10 |issue=6 |pages=e0130092 |date=2015 |pmid=26068006 |pmc=4466801 |doi=10.1371/journal.pone.0130092 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 710: | Line 709: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Brucella]] | ! align="center" style="background:#DCDCDC;" |[[Brucella]]<ref name="pmid24983999">{{cite journal |vauthors=Roset MS, Ibañez AE, de Souza Filho JA, Spera JM, Minatel L, Oliveira SC, Giambartolomei GH, Cassataro J, Briones G |title=Brucella cyclic β-1,2-glucan plays a critical role in the induction of splenomegaly in mice |journal=PLoS ONE |volume=9 |issue=7 |pages=e101279 |date=2014 |pmid=24983999 |pmc=4077732 |doi=10.1371/journal.pone.0101279 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 737: | Line 736: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Tuberculosis]] | ! align="center" style="background:#DCDCDC;" |[[Tuberculosis]]<ref name="pmid27051579">{{cite journal |vauthors=Chandni R, Chandni R, Chandni R |title=Extra pulmonary tuberculosis presenting as fever with massive splenomegaly and pancytopenia |journal=IDCases |volume=4 |issue= |pages=20–2 |date=2016 |pmid=27051579 |pmc=4802818 |doi=10.1016/j.idcr.2016.02.005 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 765: | Line 764: | ||
|- | |- | ||
! rowspan="4" align="center" style="background:#DCDCDC;" |[[Parasitism|Parasitic]] | ! rowspan="4" align="center" style="background:#DCDCDC;" |[[Parasitism|Parasitic]] | ||
! align="center" style="background:#DCDCDC;" |[[Malaria]] | ! align="center" style="background:#DCDCDC;" |[[Malaria]]<ref name="pmid26612502">{{cite journal |vauthors=Sumbele IU, Bopda OS, Kimbi HK, Ning TR, Nkuo-Akenji T |title=Influence of Plasmodium gametocyte carriage on the prevalence of fever, splenomegaly and cardiovascular parameters in children less than 15 years in the Mount Cameroon area: cross sectional study |journal=BMC Infect. Dis. |volume=15 |issue= |pages=547 |date=November 2015 |pmid=26612502 |pmc=4661959 |doi=10.1186/s12879-015-1290-4 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 792: | Line 791: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Schistosomiasis]] | ! align="center" style="background:#DCDCDC;" |[[Schistosomiasis]]<ref name="pmid25434143">{{cite journal |vauthors=Pan J, Liu L, Yan YH, Shao ZW, Li Q, Zhou RH |title=[Application of health education path in advanced schistosomiasis patients with splenomegaly in perioperative period] |language=Chinese |journal=Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi |volume=26 |issue=4 |pages=425–7, 430 |date=August 2014 |pmid=25434143 |doi= |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 819: | Line 818: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Toxoplasmosis]] | ! align="center" style="background:#DCDCDC;" |[[Toxoplasmosis]]<ref name="pmid25210646">{{cite journal |vauthors=Oz HS |title=Novel Synergistic Protective Efficacy of Atovaquone and Diclazuril on Fetal-Maternal Toxoplasmosis |journal=Int J Clin Med |volume=5 |issue=15 |pages=921–932 |date=August 2014 |pmid=25210646 |pmc=4157831 |doi= |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 846: | Line 845: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Visceral leishmaniasis|Kala-azar]] | ! align="center" style="background:#DCDCDC;" |[[Visceral leishmaniasis|Kala-azar]]<ref name="pmid24850963">{{cite journal |vauthors=Sayyahfar S, Ansari S, Mohebali M, Behnam B |title=Visceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar |journal=Korean J. Parasitol. |volume=52 |issue=2 |pages=189–91 |date=April 2014 |pmid=24850963 |pmc=4028457 |doi=10.3347/kjp.2014.52.2.189 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" |[[Visceral leishmaniasis]] | | align="center" style="background:#F5F5F5;" |[[Visceral leishmaniasis]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 873: | Line 872: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |[[Endocarditis|Infective endocarditis]] | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Endocarditis|Infective endocarditis]]<ref name="pmid25352503">{{cite journal |vauthors=Francischetto O, Silva LA, Senna KM, Vasques MR, Barbosa GF, Weksler C, Ramos RG, Golebiovski WF, Lamas Cda C |title=Healthcare-associated infective endocarditis: a case series in a referral hospital from 2006 to 2011 |journal=Arq. Bras. Cardiol. |volume=103 |issue=4 |pages=292–8 |date=October 2014 |pmid=25352503 |pmc=4206359 |doi= |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 900: | Line 899: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |[[Fungus|Fungal]] | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Fungus|Fungal]]<ref name="pmid23118473">{{cite journal |vauthors=Balakrishnan N, Jawanda JS, Miller MB, Breitschwerdt EB |title=Bartonella henselae infection in a man with hypergammaglobulinaemia, splenomegaly and polyclonal plasmacytosis |journal=J. Med. Microbiol. |volume=62 |issue=Pt 2 |pages=338–41 |date=February 2013 |pmid=23118473 |doi=10.1099/jmm.0.052134-0 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 1,094: | Line 1,093: | ||
* [[Infection|Infections]] | * [[Infection|Infections]] | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! rowspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infiltrative | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ||
Line 1,122: | Line 1,121: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |[[Gaucher's disease|Gaucher disease]]<ref name="pmid23510067">{{cite journal |vauthors=Ayto R, Hughes DA |title=Gaucher disease and myeloma |journal=Crit Rev Oncog |volume=18 |issue=3 |pages=247–68 |date=2013 |pmid=23510067 |doi= |url=}}</ref> | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Gaucher's disease|Gaucher disease]]<ref name="pmid23510067">{{cite journal |vauthors=Ayto R, Hughes DA |title=Gaucher disease and myeloma |journal=Crit Rev Oncog |volume=18 |issue=3 |pages=247–68 |date=2013 |pmid=23510067 |doi= |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | |
Revision as of 00:02, 30 September 2018
WikiDoc Resources for Splenomegaly |
Articles |
---|
Most recent articles on Splenomegaly Most cited articles on Splenomegaly |
Media |
Powerpoint slides on Splenomegaly |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Splenomegaly at Clinical Trials.gov Clinical Trials on Splenomegaly at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Splenomegaly
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Splenomegaly Discussion groups on Splenomegaly Patient Handouts on Splenomegaly Directions to Hospitals Treating Splenomegaly Risk calculators and risk factors for Splenomegaly
|
Healthcare Provider Resources |
Causes & Risk Factors for Splenomegaly |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Gichoya Judy Wawira [2], Moi University School of Medicine
Synonyms and keywords: Spleen enlargement; enlarged spleen; spleen swelling
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Splenomegaly from Other Diseases
Category | Disease | Etiology | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | Lab Findings | Imaging | ||||||||||||||||||||||
Fever | Fatigue | Weight | Abdominal pain | Bleeding | BP | JVP | Jaundice | Ascites | Other | CBC | Iron | LFT | PT/PTT | BUN/Cr | UA | Histopathology | |||||||||||
WBC | Hb | Plt | |||||||||||||||||||||||||
Congestive | Cirrhosis[1] | Any, more in elderly | – | + | ↑↓ | + | + | ↓ | Nl | + | + | ↓ | ↓ | ↓ | Nl | ↑ | ↑ | ↑ |
|
|
|
Liver biopsy | |||||
Heart failure[2] | Elderly |
|
– | + | ↑↓ | – | – | ↑ | ↑ | ± | + | ↓ | ↓ | ↑ | Nl | ↑ | ↑ | ↑ | Nl | NA |
|
Echocardiography |
| ||||
Thrombosis of portal, hepatic, or splenic veins[3] | Any | + | + | ↑ | + | + | ↓ | Nl | ± | + | ↓ | ↓ | ↓ | Nl | ↑ | ↑ | ↑ |
|
NA |
|
Doppler ultrasonography | ||||||
Malignancy | Lymphoma[4] | Any, most common malignant splenic tumor |
|
+ | + | ↓ | + | + | Nl | Nl | + | – | ↓ | ↓ | ↓ | High ferritin | ↑ | ↑ | ↑ | Nl |
|
|
Lymph node biopsy | ||||
Leukemia[5] |
|
Elderly, male>female |
|
+ | + | ↓ | + | + | Nl | Nl | ± | + | ↓ | ↓ | ↓ | High ferritin | ↑ | ↑ | ↑ | Nl |
|
NA | Bone marrow examination + clinical manifestation |
| |||
Polycythemia Vera[6] |
|
Mean age >60 years old |
|
– | + | Nl | + | – | Nl | Nl | – | – |
|
Nl to ↑ | ↑ | Nl to ↑ | High ferritin | Nl | Nl | Nl | Nl |
|
NA | WHO criteria for PV | |||
Disease | Etiology | Demography | History | Fever | Fatigue | Weight loss | Abdominal pain | Bleeding | BP | JVP | Jaundice | Ascites | Other | WBC | Hb | Plt | Iron | LFT | PT/PTT | BUN/Cr | UA | Histopathology | Imaging | Gold standard | Associated findings | ||
Multiple myeloma[7] | Any, more in adults |
|
+ | + | ↓ | + | + | Nl | Nl | + | – | ↓ | ↓ | ↓ | High ferritin | Nl | ↑ | ↑ |
|
Bone marrow examination |
| ||||||
Essential thrombocythemia[8] |
|
Mean age >60 years old, female > male |
|
± | + | Nl | + | + | Nl | Nl | – | – | ↑ | ↑ | ↑↑ | Nl | Nl | Nl | Nl | Nl |
|
|
Bone marrow biopsy | ||||
Primary myelofibrosis[9] |
|
Mean age >60 years old, male> female |
|
– | + | Nl | + | + | Nl | Nl | + | – | ↓ | ↓ | ↑/↓ | Low iron | Nl | ↑ | Nl |
|
Bone marrow biopsy |
| |||||
Primary splenic tumors[10] | Rare | ||||||||||||||||||||||||||
Metastatic solid tumors[11] |
|
Any, more in adults |
|
+ | + | ↓ | + | + | ↓ | Nl | ± | ± | ↓ | ↓ | ↓ | Low iron, high ferritin | ↑ | ↑ | ↑ |
|
Biopsy |
| |||||
Disease | Etiology | Demography | History | Fever | Fatigue | Weight | Abdominal pain | Bleeding | BP | JVP | Jaundice | Ascites | Other | WBC | Hb | Plt | Iron | LFT | PT/PTT | BUN/Cr | UA | Histopathology | Imaging | Gold standard | Associated findings | ||
Infection | Viral | Hepatitis[12] |
|
Any |
|
+ | + | ↓ | + | + | Nl | Nl | + | + |
|
↓ | ↓ | ↓ | Nl | ↑ | ↑ | ↑ | Clinical manifestation + lab tests |
| |||
Infectious mononucleosis[13] |
|
||||||||||||||||||||||||||
Cytomegalovirus[14] | |||||||||||||||||||||||||||
Bacterial | Salmonella[15] | ||||||||||||||||||||||||||
Brucella[16] | |||||||||||||||||||||||||||
Tuberculosis[17] | |||||||||||||||||||||||||||
Parasitic | Malaria[18] | ||||||||||||||||||||||||||
Schistosomiasis[19] | |||||||||||||||||||||||||||
Toxoplasmosis[20] | |||||||||||||||||||||||||||
Kala-azar[21] | Visceral leishmaniasis | ||||||||||||||||||||||||||
Infective endocarditis[22] | |||||||||||||||||||||||||||
Fungal[23] | |||||||||||||||||||||||||||
Disease | Etiology | Demography | History | Fever | Fatigue | Weight loss | Abdominal pain | Bleeding | BP | JVP | Jaundice | Ascites | Other | WBC | Hb | Plt | Iron | LFT | PT/PTT | BUN/Cr | UA | Histopathology | Imaging | Gold standard | Associated findings | ||
Inflammation | Sarcoidosis |
|
Autoimmune disease, more in young African American women |
|
+ | + | ↓ | + | + | Nl | Nl | - | - | ↑ | ↓ | ↑ | Nl | Nl | Nl | Nl | Nl | NA |
|
Diagnosis of exclusion |
| ||
Serum sickness | |||||||||||||||||||||||||||
Systemic lupus erythematosus |
|
More in young females |
|
+ | + | ↓ | + | + | Nl to ↓ | Nl | + | + | ↓ | ↓ | ↓ | ↑ | ↑ | ↑ |
|
Clinical findings + laboratory studies |
| ||||||
Felty syndrome |
|
Rare autoimmune disease, more in females 50-70 years old |
|
+ | + | ↓ | + | + | Nl to ↓ | Nl | + | + |
|
↓ | ↓ | ↓ | Nl | Nl | Nl | Nl | Nl |
|
Clinical findings + laboratory studies | ||||
Infiltrative | Disease | Etiology | Demography | History | Fever | Fatigue | Weight loss | Abdominal pain | Bleeding | BP | JVP | Jaundice | Ascites | Other | WBC | Hb | Plt | Iron | LFT | PT/PTT | BUN/Cr | UA | Histopathology | Imaging | Gold standard | Associated findings | |
Gaucher disease[24] |
|
Rare, mostly in children |
|
- | + | ↓ | + | + | Nl to ↓ | Nl | + | + | ↓ | ↓ | ↓ | Nl | Nl | ↑ | ↑ |
|
Clinical findings + laboratory studies | ||||||
Niemann-Pick disease | |||||||||||||||||||||||||||
Amyloidosis | |||||||||||||||||||||||||||
Langerhans cell histiocytosis | |||||||||||||||||||||||||||
Hemophagocytic lymphohistiocytosis | |||||||||||||||||||||||||||
Rosai-Dorfman disease | |||||||||||||||||||||||||||
Hematologic (hypersplenic) states | Hemolytic anemia | ||||||||||||||||||||||||||
Sickle cell disease | |||||||||||||||||||||||||||
Granulocyte colony-stimulating factor | |||||||||||||||||||||||||||
Disease | Etiology | Demography | History | Fever | Fatigue | Weight loss | Abdominal pain | Bleeding | BP | JVP | Jaundice | Ascites | Other | WBC | Hb | Plt | Iron | LFT | PT/PTT | BUN/Cr | UA | Histopathology | Imaging | Gold standard | Associated findings |
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Treatment
Case Studies
Related Chapters
References
- ↑ Wu Z, Zhou J, Pankaj P, Peng B (December 2012). "Laparoscopic and open splenectomy for splenomegaly secondary to liver cirrhosis: an evaluation of immunity". Surg Endosc. 26 (12): 3557–64. doi:10.1007/s00464-012-2366-5. PMID 22710653.
- ↑ Gedela M, Khan M, Jonsson O (September 2015). "Heart Failure". S D Med. 68 (9): 403–5, 407–9. PMID 26489162.
- ↑ Ferri PM, Ferreira AR, Fagundes ED, Liu SM, Roquete ML, Penna FJ (2012). "Portal vein thrombosis in children and adolescents: 20 years experience of a pediatric hepatology reference center". Arq Gastroenterol. 49 (1): 69–76. PMID 22481689.
- ↑ Ishibashi N, Maebayashi T, Aizawa T, Sakaguchi M, Abe O, Saito T, Tanaka Y (May 2015). "Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma". Hematology. 20 (4): 203–7. doi:10.1179/1607845414Y.0000000192. PMID 25131182.
- ↑ Quest GR, Johnston JB (December 2015). "Clinical features and diagnosis of hairy cell leukemia". Best Pract Res Clin Haematol. 28 (4): 180–92. doi:10.1016/j.beha.2015.10.017. PMID 26614896.
- ↑ Chou YS, Gau JP, Yu YB, Pai JT, Hsiao LT, Liu JH, Hong YC, Liu CY, Yang CF, Chen PM, Chiou TJ, Tzeng CH (March 2013). "Leukocytosis in polycythemia vera and splenomegaly in essential thrombocythemia are independent risk factors for hemorrhage". Eur. J. Haematol. 90 (3): 228–36. doi:10.1111/ejh.12064. PMID 23281576.
- ↑ Grieco A, Manna R, Mancini R, Gambassi G (April 1988). "Massive hepatomegaly following splenectomy for myeloid metaplasia". Am. J. Med. 84 (4): 797. PMID 3400674.
- ↑ Tefferi A, Barbui T (February 2015). "Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management". Am. J. Hematol. 90 (2): 162–73. doi:10.1002/ajh.23895. PMID 25611051.
- ↑ Cervantes F, Martinez-Trillos A (May 2013). "Myelofibrosis: an update on current pharmacotherapy and future directions". Expert Opin Pharmacother. 14 (7): 873–84. doi:10.1517/14656566.2013.783019. PMID 23514013.
- ↑ Adachi K, Ui M, Nojima H, Takada Y, Enatsu K (August 2011). "Isolated splenic peliosis presenting with giant splenomegaly and severe coagulopathy". Am. J. Surg. 202 (2): e17–9. doi:10.1016/j.amjsurg.2010.10.002. PMID 21810495.
- ↑ Huprikar NA, Kurtz MT, Mount CA (October 2013). "Massive splenomegaly and lymphopenia: a unique case of obstructive shock". BMJ Case Rep. 2013. doi:10.1136/bcr-2013-201643. PMC 3822246. PMID 24172780.
- ↑ Kumar KJ, Kumar HC, Manjunath VG, Anitha C, Mamatha S (January 2014). "Hepatitis A in children- clinical course, complications and laboratory profile". Indian J Pediatr. 81 (1): 15–9. doi:10.1007/s12098-013-1114-8. PMID 23904062.
- ↑ Gao LW, Xie ZD, Liu YY, Wang Y, Shen KL (February 2011). "Epidemiologic and clinical characteristics of infectious mononucleosis associated with Epstein-Barr virus infection in children in Beijing, China". World J Pediatr. 7 (1): 45–9. doi:10.1007/s12519-011-0244-1. PMID 21191775.
- ↑ Smiechura M, Strużycka M, Konopka W (2014). "Congenital and acquired cytomegalovirus infection and hearing evaluation in children". Otolaryngol Pol. 68 (6): 303–7. doi:10.1016/j.otpol.2014.04.003. PMID 25308607.
- ↑ Rosche KL, Aljasham AT, Kipfer JN, Piatkowski BT, Konjufca V (2015). "Infection with Salmonella enterica Serovar Typhimurium Leads to Increased Proportions of F4/80+ Red Pulp Macrophages and Decreased Proportions of B and T Lymphocytes in the Spleen". PLoS ONE. 10 (6): e0130092. doi:10.1371/journal.pone.0130092. PMC 4466801. PMID 26068006.
- ↑ Roset MS, Ibañez AE, de Souza Filho JA, Spera JM, Minatel L, Oliveira SC, Giambartolomei GH, Cassataro J, Briones G (2014). "Brucella cyclic β-1,2-glucan plays a critical role in the induction of splenomegaly in mice". PLoS ONE. 9 (7): e101279. doi:10.1371/journal.pone.0101279. PMC 4077732. PMID 24983999.
- ↑ Chandni R, Chandni R, Chandni R (2016). "Extra pulmonary tuberculosis presenting as fever with massive splenomegaly and pancytopenia". IDCases. 4: 20–2. doi:10.1016/j.idcr.2016.02.005. PMC 4802818. PMID 27051579.
- ↑ Sumbele IU, Bopda OS, Kimbi HK, Ning TR, Nkuo-Akenji T (November 2015). "Influence of Plasmodium gametocyte carriage on the prevalence of fever, splenomegaly and cardiovascular parameters in children less than 15 years in the Mount Cameroon area: cross sectional study". BMC Infect. Dis. 15: 547. doi:10.1186/s12879-015-1290-4. PMC 4661959. PMID 26612502.
- ↑ Pan J, Liu L, Yan YH, Shao ZW, Li Q, Zhou RH (August 2014). "[Application of health education path in advanced schistosomiasis patients with splenomegaly in perioperative period]". Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi (in Chinese). 26 (4): 425–7, 430. PMID 25434143.
- ↑ Oz HS (August 2014). "Novel Synergistic Protective Efficacy of Atovaquone and Diclazuril on Fetal-Maternal Toxoplasmosis". Int J Clin Med. 5 (15): 921–932. PMC 4157831. PMID 25210646.
- ↑ Sayyahfar S, Ansari S, Mohebali M, Behnam B (April 2014). "Visceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar". Korean J. Parasitol. 52 (2): 189–91. doi:10.3347/kjp.2014.52.2.189. PMC 4028457. PMID 24850963.
- ↑ Francischetto O, Silva LA, Senna KM, Vasques MR, Barbosa GF, Weksler C, Ramos RG, Golebiovski WF, Lamas Cda C (October 2014). "Healthcare-associated infective endocarditis: a case series in a referral hospital from 2006 to 2011". Arq. Bras. Cardiol. 103 (4): 292–8. PMC 4206359. PMID 25352503.
- ↑ Balakrishnan N, Jawanda JS, Miller MB, Breitschwerdt EB (February 2013). "Bartonella henselae infection in a man with hypergammaglobulinaemia, splenomegaly and polyclonal plasmacytosis". J. Med. Microbiol. 62 (Pt 2): 338–41. doi:10.1099/jmm.0.052134-0. PMID 23118473.
- ↑ Ayto R, Hughes DA (2013). "Gaucher disease and myeloma". Crit Rev Oncog. 18 (3): 247–68. PMID 23510067.